748 related articles for article (PubMed ID: 19351465)
21. Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients.
Moran CJ; Kell MR; Flanagan FL; Kennedy M; Gorey TF; Kerin MJ
Am J Surg; 2007 Aug; 194(2):172-5. PubMed ID: 17618799
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of predictive factors, particularly the Van Nuys index, of local recurrence in ductal carcinoma in situ of the breast: study of 166 cases with conservative treatment and review of the literature].
Denoux Y; Marnay J; Crouet H; Boute V; Delozier T; Vie B; Chasle J
Bull Cancer; 2001 Apr; 88(4):419-25. PubMed ID: 11371378
[TBL] [Abstract][Full Text] [Related]
23. [Conservative surgery for ductal carcinoma in situ of the breast].
Tersigni R; Mencacci R; Alessandroni L; Baiano G; Mardarella C; Parisi A
Minerva Chir; 2003 Aug; 58(4):563-9. PubMed ID: 14603170
[TBL] [Abstract][Full Text] [Related]
24. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
Westenberg AH; Rutgers EJ; Peterse JL; Hendriks JH; Beex LV; van Tienhoven G
Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2157-61. PubMed ID: 14626831
[TBL] [Abstract][Full Text] [Related]
25. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
[TBL] [Abstract][Full Text] [Related]
26. Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast.
Macdonald HR; Silverstein MJ; Lee LA; Ye W; Sanghavi P; Holmes DR; Silberman H; Lagios M
Am J Surg; 2006 Oct; 192(4):420-2. PubMed ID: 16978941
[TBL] [Abstract][Full Text] [Related]
27. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
Mechera R; Viehl CT; Oertli D
Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
[TBL] [Abstract][Full Text] [Related]
28. [New therapeutic perspectives in breast ductal carcinoma in situ].
Ladekarl M; Grau C; Andersen J
Ugeskr Laeger; 2001 Sep; 163(37):5014-7. PubMed ID: 11573374
[TBL] [Abstract][Full Text] [Related]
29. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.
Dominguez FJ; Golshan M; Black DM; Hughes KS; Gadd MA; Christian R; Lesnikoski BA; Specht M; Michaelson J; Smith BL
Ann Surg Oncol; 2008 Jan; 15(1):268-73. PubMed ID: 17891441
[TBL] [Abstract][Full Text] [Related]
30. Ultrasonography- and/or mammography-guided breast conserving surgery for ductal carcinoma in situ of the breast: experience with 87 lesions.
Hayashi N; Tsunoda H; Abe E; Kikuchi M; Enokido K; Tsugawa K; Suzuki K; Nakamura S
Breast Cancer; 2012 Apr; 19(2):131-7. PubMed ID: 20725871
[TBL] [Abstract][Full Text] [Related]
31. Occult "micrometastases" in ductal carcinoma in situ: investigative implications for sentinel lymph node biopsy.
Weaver DL
Cancer; 2003 Nov; 98(10):2083-7. PubMed ID: 14601075
[No Abstract] [Full Text] [Related]
32. Recent advances and current controversies in the management of DCIS of the breast.
Sakorafas GH; Farley DR; Peros G
Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
[TBL] [Abstract][Full Text] [Related]
33. Contemporary treatment of ductal carcinoma in situ of the breast.
Mokbel K
Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
[TBL] [Abstract][Full Text] [Related]
34. Intraduct carcinoma of the breast (duct carcinoma in situ).
Lange M; Kessel I; Kessler E; Lakier RH; Lange NR; Ross-Thompson S
S Afr J Surg; 1994 Jun; 32(2):59-61. PubMed ID: 7502173
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy and tamoxifen after breast-conserving surgery for DCIS.
Cunnick GH; Mokbel K
Int J Fertil Womens Med; 2004; 49(5):237-8. PubMed ID: 15633483
[TBL] [Abstract][Full Text] [Related]
36. Margin status after breast-conserving treatment of breast cancer: how much free margin is enough?
von Smitten K
J Surg Oncol; 2008 Dec; 98(8):585-7. PubMed ID: 19072849
[TBL] [Abstract][Full Text] [Related]
37. Ductal carcinoma in situ of the breast -- among factors predicting for recurrence, distance from the nipple is important.
Stallard S; Hole DA; Purushotham AD; Hiew LY; Mehanna H; Cordiner C; Dobson H; Mallon EA; George WD
Eur J Surg Oncol; 2001 Jun; 27(4):373-7. PubMed ID: 11417983
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node mapping and biopsy for ductal carcinoma in situ and other controversial indications.
Fuhrman GM
Am Surg; 2004 May; 70(5):403-6. PubMed ID: 15156947
[TBL] [Abstract][Full Text] [Related]
39. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
[TBL] [Abstract][Full Text] [Related]
40. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
Sanders ME; Schuyler PA; Dupont WD; Page DL
Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
